2007;4(8):432-443. Raman and colleagues reported that, following definitive surgical resection of upper-tract TCC (nephroureterectomy or segmental ureterectomy), bladder tumors developed in 44% of ...

AREALISTIC appraisal of knowledge concerning neoplastic disease in general and that affecting the organs of the genitourinary tract in particular leads to the conclusion that, although the ...

releasing mitomycin to target any remaining cancer cells. Because the mitomycin is gel-based, it remains in contact with the ...

—With data from the Nurses’ Health Study and the Health Professionals Follow-Up Study, these investigators found that people with recent, unintended weight loss had a significantly higher risk ...

The study included 22 patients with intact primary tumors, with 59.1% receiving Padcev ... carcinoma lesions were shared at the 2025 ASCO Genitourinary Cancers Symposium. Among patients with upper ...

and particularly in patients with upper tract [urothelial cancer].” An abstract presented at ASCO GU presented the findings of a retrospective analysis of the radiographic response of patients ...

Tumor-ablative chemotherapy for low-grade upper tract urothelial carcinoma (UTUC ... of Garden State Urology and Director of Genitourinary Surgical Oncology at Morristown Medical Center/Atlantic ...

Bladder cancer is a common occurrence following the management of upper-tract TCC. Currently, there are no variables that consistently predict which patients will develop intravesical recurrences.